Toxicity and efficacy of ifosfamide, carboplatin and etoposide (modified ICE) as a salvage chemotherapy in Japanese patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
スポンサーリンク
概要
- 論文の詳細を見る
- 1998-12-01
著者
-
MINAMI Hironobu
Division of Oncology and Hematology, National Cancer Center Hospital East
-
ITOH Kuniaki
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Minami H
Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine
-
Minami Hironobu
神戸大学 医学研究科腫瘍内科学
-
Minami Hironobu
名古屋第一赤十字病院
-
Minami Hironobu
National Cancer Center Hospital East
-
OHTSU Tomoko
Amgen Limited
-
OHTSU Tomoko
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
FUJII Hirofumi
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
IGARASHI Tadahiko
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
SASAKI Yasutsuna
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
Itoh K
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Igarashi T
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Igarashi Tadahiko
神戸大学 医学研究科腫瘍内科学
-
Igarashi Tadahiko
国立がんセンター東病院
-
Igarashi Tadahiko
Division Of Hematology And Oncology National Cancer Center Hospital East
-
Ichimura Koichi
Department Of Hematology And Rheumatology Tohoku University Graduate School Of Medicine
-
Ishizawa Kenichi
東北大学 血液･免疫病学分野
-
Ishizawa Kenichi
国立がんセンター東病院
-
SASAKI Yasutsuna
National Cancer Center Hospital East
-
Minami H
Department Of Hematology Fujita Health University School Of Medicine
-
Mukai Hirofumi
国立がんセンター東病院 化学療法科血液
-
WAKITA Hisashi
Division of Hematology and Oncology, Japanese Red Cross Narita Hospital
-
Itoh Kuniaki
Division Of Oncology And Hematology National Cancer Center Hospital East
-
WATANABE Yuko
Division of Hematology and Oncology, National Cancer Center Hospital East
-
Fujii H
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Mukai Hirofumi
National Cancer Center Hospital East Oncology/hematology
-
Minami Hironobu
The Division Of Oncology/hematology National Cancer Center Hospital East
-
Minami Hironobu
Oncology/hematology National Cancer Center Hospital East
-
Ohtsu Tomoko
Amgen Kk
-
Sasaki Yasutsuna
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Ichimura Koichi
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Fujii Hirofumi
Division Of Hematology/oncology Beth Israel Deaconess Medical Center
-
Fujii Hideji
Research Laboratories Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Mitsuya Hiroaki
Department Of Hematology And Infectious Diseases Kumamoto University Graduate School Of Medical Scie
-
Wakita Hisashi
Division Of Hematology And Oncology National Cancer Center Hospital East
-
Wakita Hisashi
Division Of Hematology And Oncology Japanese Red Cross Narita Hospital
-
Minami Hironobu
National Cancer Center Hospital East Oncology/hematology
-
Ohtsu Tomoko
Division Of Oncology/hematology National Cancer Center Hospital East
-
Itoh Kuniaki
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Mukai Hirofumi
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Sasaki Yasutsuna
Division Of Hematology And Oncology National Cancer Center Hospital East
-
Takahashi Isao
Second Department Of Internal Medicine Okayama University Medical School
-
Ohtsu Tomoko
Amgen Kk Tokyo Jpn
-
Watanabe Yuko
Division Of Hematology And Oncology National Cancer Center Hospital East
-
Minami Hironobu
Division Of Medical Oncology/hematology Department Of Medicine Kobe University Graduate School Of Me
-
Itoh Kuniaki
Division of Hematology and Oncology, National Cancer Center Hospital East
-
Ohtsu Tomoko
Division of Hematology and Oncology, National Cancer Center Hospital East
関連論文
- Genetic Variations and Haplotypes of ABCC2 Encoding MRP2 in a Japanese Population
- Extreme eosinophilia caused by interleukin-5-producing disseminated colon cancer
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Twelve Novel Single Nucleotide Polymorphisms in the CES2 Gene Encoding Human Carboxylesterase 2 (hCE-2)
- Clonal Analysis of Bilateral, Recurrent, or Systemically Multifocal Ocular Adnexal Lymphoma
- Genetic Variations and Frequencies of Major Haplotypes in SLCO1B1 Encoding the Transporter OATP1B1 in Japanese Subjects : SLCO1B1^*17 is More Prevalent Than ^*15
- 日本人におけるヒトSLC29A1の新規遺伝子多型の同定
- Genetic Variation and Haplotype Structure of the ABC Transporter Gene ABCG2 in a Japanese Population
- Genetic Variations and Haplotypes of UGT1A4 in a Japanese Population
- Genetic Polymorphisms of UGT1A6 in a Japanese Population
- Genetic Variations of the AHR Gene Encoding Aryl Hydrocarbon Receptor in a Japanese Population
- Three Novel Single Nucleotide Polymorphisms in UGT1A9
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Novel Genetic Polymorphisms in the NR3C1 (Glucocorticoid receptor) Gene in a Japanese Population
- Twenty-six Novel Single Nucleotide Polymorphisms and their Frequencies of the NR113 (CAR) Gene in a Japanese Population
- Eight Novel Single Nucleotide Polymorphisms in ABCG2/BCRP in Japanese Cancer Patients Administered Irinotacan
- Eight Novel Single Nucleotide Polymorphisms in ABCG2/BCRP in Japanese Cancer Patients Administered Irinotacan
- Three novel single nucleotide polymorphisms in UGT1A10
- Phase 1 trial of denosumab safety, pharmacokinetics, and pharmacodynamics in Japanese women with breast cancer-related bone metastases
- Phase I Study of Intravenous PSC-833 and Doxorubicin: Reversal of Multidrug Resistance
- Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
- Acquired hemophilia A with sigmoid colon cancer : successful treatment with rituximab followed by sigmoidectomy
- A retrospective analysis of bortezomib therapy for Japanese patients with relapsed or refractory multiple myeloma : β2-microglobulin associated with time to progression
- Dose Modification of Imatinib by Monitoring the Level of BCR-ABL Transcript in Chronic Myelogenous Leukemia
- Increased Expression of Insulin-Like Growth Factor I is Associated with Ara-C Resistance in Leukemia
- Imatinib Mesylate in Conjunction with Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Philadelphia Chromosome Positive Leukemias : Report of 4 Cases
- Detection of Clone-Specific Immunoglobulin Heavy Chain Genes in the Bone Marrow of B-cell-Lineage Lymphoma after Treatment
- High Expression of YB-1 Gene in Erythroid Cells in Patients with Refractory Anemia
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Case-control study of leukemia and diagnostic radiation exposure
- Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura
- Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice
- Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients
- Extragonadal germ cell tumors in Japan
- Treatable Subsets in Cancer of Unknown Primary Origin
- Toxicity and efficacy of ifosfamide, carboplatin and etoposide (modified ICE) as a salvage chemotherapy in Japanese patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
- Recurrent Breast Cancer Treated Successfully with Mitomycin-C and Vinblastine after Failure of Both Doxorubicin-containing Regimen and Paclitaxel : A Case Report
- A Limited Sampling Model for Estimating Pharmacokinetics of CPT-11 and Its Metabolite SN-38
- Pharmacological Correlation between Total Drug Concentration and Lactones of CPT-11 and SN-38 in Patients Treated with CPT-11
- Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Population pharmacokinetic and pharmacodynamic analysis for time courses of docetaxel-induced neutropenia in Japanese cancer patients
- Fludarabine- and Cyclophosphamide-Based Nonmyelobalative Conditioning Regimen for Transplantation of Chronic Granulomatous Disease : Possible Correlation with Prolonged Pure Red Cell Aplasia
- Microbial Serine Carboxypeptidase Inhibitors : Comparative Analysis of Actions on Homologous Enzymes Derived from Man, Yeast and Wheat
- Stereoscopic Scintigraphic Imaging of Breast Cancer Sentinel Lymph Nodes
- Effect of axitinib (AG-013736) on fatigue, thyroid-stimulating hormone, and biomarkers : A phase I study in Japanese patients
- Clinical, biochemical, and cytochemical studies on a Japanese Salla disease case associated with a renal disorder
- What is the most informative pharmacodynamic model for paclitaxel (T)? : a 3 hour-infusion vs. 24-hour infusion.
- Photo-Induced Reactions of Oxime O-Ethers Derived from 3-Acyl-1, 2-dihydrocinnoline- 1, 2-dicarboximides
- Novel Photo-Rearrangement of Oxime Methyl Ethers of 3-Acyl-1, 2dihydrocinnoline-N-phenyl-1, 2-dicarboximides
- Phase I Study of Paclitaxel by Three-hour Infusion : Hypotension Just after Infusion Is One of the Major Dose-limiting Toxicities
- Oblique view of preoperative lymphoscintigraphy improves detection of sentinel lymph nodes in esophageal cancer
- Positron Emission Tomography/Computed Tomography after Immunocytochemical and Clonal Diagnosis of Intraocular Lymphoma with Vitrectomy Cell Blocks
- Prognostic Factors for Short-term Survival in Patients with Stage IV Non-small Cell Lung Cancer
- Pharmacokinetic Study of Carboplatin Given on a 5-Day Intravenous Schedule
- Therapeutic Drug Monitoring in 21-Day Oral Etoposide Treatment for Lung Cancer
- Therapeutic Drug Monitoring of Etoposide in a 14-Day Infusion for Non-small-cell Lung Cancer
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3-Hour Infusion of Paclitaxel
- Serum soluble interleukin-2 receptor level and immunophenotype are prognostic factors for patients with diffuse large B-cell lymphoma
- A Pharmacokinetic and Pharmacodynamic Analysis of CPT-11 and Its Active Metabolite SN-38
- Frequent downregulation or loss of CD79a expression in plasma cell myelomas : Potential clue for diagnosis
- Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer
- Correlation Between Histological Evaluation and PCR-based Clonality Analysis of Gastric MALT Lymphomas Treated by Eradication of Helicobacter pylori
- Occult Thymic Carcinoma Presenting as Malignant Cardiac Tamponade
- Immunoglobulin G4 (IgG4)-Positive or -Negative Ocular Adnexal Benign Lymphoid Lesions in Relation to Systemic Involvement
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- BAFF-R is Expressed on B-cell Lymphomas Depending on their Origin, and its Related to Proliferation Index of Nodal Diffuse Large B-cell Lymphomas
- Review of primary unknown cancer : cases referred to the National Cancer Center Hospital East
- Phase I dose escalation and pharmacokinetic study of oral enzastaurin (LY317615) in advanced solid tumors
- Comparison of Long-Term Clinical Outcomes of CHOP Chemotherapy between Japanese Patients with Nodal Peripheral T-Cell Lymphomas and Those with Diffuse Large B-Cell Lymphoma in the Study Group of the Tohoku Hematology Forum
- Bilateral Conjunctival Lesions in Blastic Plasmacytoid Dendritic Cell Neoplasm
- Clinicopathological Features of Malignant Lymphoma in Japan : The Miyagi Study
- Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
- Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation
- Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
- Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene
- Successful neutrophil engraftment by reduced use of granulocyte colony-stimulating factor after allogeneic hematopoietic stem cell transplantation with mycophenolate mofetil for graft-versus-host disease prophylaxis
- Neurotoxins, 1-methy1-4-phenyl-1, 2, 3, 6-tetrahydropyridine, 1, 2, 3, 4, -tetrahydroisoquinoline, N-methyl-tetrahydroisoquinoline and 1-benzyl-tetrahydroisoquinoline, are substrates for rat liver flavin-containing monooxygenase(FMO) expressed in yeast
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
- Local Recurrence as Immunoglobulin G4 (IgG4)-Related Disease 10 Years after Radiotherapy to Ocular Adnexal Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue
- Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria
- Diagnosis of Intestinal Graft-versus-Host Disease and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation